BA
AMGN icon

Bridgewater Associates’s Amgen AMGN Stock Holding History

Bridgewater Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.2M Buy
14,774
+11,754
+389% +$4.19M 0.02% 412
2025
Q4 		$988K Sell
3,020
-8,275
-73% -$2.62M ﹤0.01% 890
2025
Q3 		$3.19M Buy
11,295
+3,860
+52% +$1.12M 0.01% 604
2025
Q2 		$2.08M Buy
+7,435
New +$2.11M 0.01% 418
2025
Q1 		– Sell
-1,415
Closed -$369K – 677
2024
Q4 		$369K Sell
1,415
-1,957
-58% -$581K ﹤0.01% 607
2024
Q3 		$1.09M Sell
3,372
-5,354
-61% -$1.75M 0.01% 588
2024
Q2 		$2.73M Sell
8,726
-7,692
-47% -$2.26M 0.01% 481
2024
Q1 		$4.67M Sell
16,418
-128,065
-89% -$37.5M 0.02% 385
2023
Q4 		$41.6M Buy
144,483
+116,758
+421% +$31.8M 0.23% 79
2023
Q3 		$7.45M Sell
27,725
-138,503
-83% -$34.6M 0.05% 283
2023
Q2 		$36.9M Buy
166,228
+1,835
+1% +$426K 0.23% 86
2023
Q1 		$39.7M Buy
164,393
+152,566
+1,290% +$37.5M 0.24% 83
2022
Q4 		$3.11M Buy
11,827
+1,583
+15% +$424K 0.02% 455
2022
Q3 		$2.31M Sell
10,244
-44,542
-81% -$10.8M 0.01% 531
2022
Q2 		$13.3M Buy
54,786
+398
+0.7% +$97.5K 0.06% 275
2022
Q1 		$13.2M Buy
54,388
+28,510
+110% +$6.55M 0.05% 241
2021
Q4 		$5.82M Sell
25,878
-11,964
-32% -$2.53M 0.03% 264
2021
Q3 		$8.05M Buy
37,842
+8,743
+30% +$2.01M 0.04% 224
2021
Q2 		$7.09M Buy
29,099
+28,049
+2,671% +$6.9M 0.05% 273
2021
Q1 		$261K Sell
1,050
-7,150
-87% -$1.71M ﹤0.01% 426
2020
Q4 		$1.89M Buy
+8,200
New +$1.89M 0.02% 313
2018
Q2 		– Sell
-62,499
Closed -$10.7M – 468
2018
Q1 		$10.7M Buy
62,499
+46,512
+291% +$8.54M 0.1% 61
2017
Q4 		$2.78M Sell
15,987
-43,286
-73% -$7.66M 0.02% 138
2017
Q3 		$11.1M Buy
59,273
+32,857
+124% +$5.82M 0.07% 70
2017
Q2 		$4.55M Sell
26,416
-25,044
-49% -$4.07M 0.04% 102
2017
Q1 		$8.44M Buy
+51,460
New +$8.55M 0.1% 64
2016
Q3 		– Sell
-38,300
Closed -$5.83M – 307
2016
Q2 		$5.83M Buy
+38,300
New +$5.95M 0.07% 109
2015
Q4 		– Sell
-62,033
Closed -$8.58M – 276
2015
Q3 		$8.58M Buy
62,033
+19,460
+46% +$3.07M 0.11% 82
2015
Q2 		$6.54M Buy
42,573
+38,200
+874% +$6.12M 0.06% 79
2015
Q1 		$699K Buy
+4,373
New +$689K 0.01% 231
2014
Q1 		– Sell
-7,513
Closed -$857K – 343
2013
Q4 		$857K Buy
+7,513
New +$855K 0.01% 250
2013
Q3 		– Sell
-83,244
Closed -$8.21M – 320
2013
Q2 		$8.21M Buy
+83,244
New +$8.64M 0.07% 49

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bridgewater Associates's AMGN Position: Q1 2026 in Review

Bridgewater Associates increased its Amgen (AMGN) stake by 389% in Q1 2026, buying an estimated $4.19M and bringing the position to 14,774 shares worth $5.2M. The position accounts for 0.02% of the portfolio, ranked #412.

Bridgewater Associates first reported a position in AMGN in Q2 2013 and has held it in 32 quarters since. The position peaked at $41.6M in Q4 2023. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bridgewater Associates held 14,774 shares of Amgen worth $5.2M as of Q1 2026.
  • Bridgewater Associates bought 11,754 Amgen shares in Q1 2026, an estimated $4.19M.
  • Amgen made up 0.02% of Bridgewater Associates's portfolio in Q1 2026, its #412 holding.
  • Bridgewater Associates first reported a position in Amgen in Q2 2013 and has held it in 32 quarters since.
  • Bridgewater Associates's Amgen position peaked at $41.6M in Q4 2023.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.